Nikocado Avocado, the popular YouTuber who shocked the internet with his 250-pound weight loss transformation last year, is ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive growth. The number of Americans taking GLP-1s for weight loss rose more ...

Dr. Sue Mitchell is an experienced gastroenterologist with a background in functional medicine, internal medicine and ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

Zero Doubt Club, a Northeast Ohio-based wellness center, has introduced a GLP-1 weight-loss program that combines medical ...

What’s the most effective way to lose weight? If you immediately thought “diet and exercise,” you’re not far off. But according to a new weight loss survey from Everyday Health ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...